Chatham Capital Group’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-20,606
Closed -$701K 187
2021
Q4
$701K Sell
20,606
-1,765
-8% -$64.1K 0.13% 134
2021
Q3
$969K Sell
22,371
-238
-1% -$14.6K 0.19% 116
2021
Q2
$1.47M Buy
22,609
+3
+0% +$190 0.28% 88
2021
Q1
$1.19M Buy
22,606
+1,024
+5% +$51.1K 0.25% 100
2020
Q4
$964K Hold
21,582
0.22% 103
2020
Q3
$626K Buy
21,582
+57
+0.3% +$1.79K 0.15% 114
2020
Q2
$765K Buy
21,525
+115
+0.5% +$4.85K 0.2% 103
2020
Q1
$1.11M Buy
+21,410
New +$1.03M 0.33% 74

Other funds holding INGN

Chatham Capital Group's INGN Position: Q1 2022 in Review

Chatham Capital Group sold out of Inogen (INGN) in Q1 2022, closing a stake of 20,606 shares — an estimated $701K sold.

Chatham Capital Group first reported a position in INGN in Q1 2020 and held it in 8 quarters. The position peaked at $1.47M in Q2 2021. 149 funds tracked by Wall St. Rank hold INGN as of Q1 2022.

  • Chatham Capital Group reported no remaining Inogen position as of Q1 2022 after selling out during the quarter.
  • Chatham Capital Group sold 20,606 Inogen shares in Q1 2022, an estimated $701K.
  • Chatham Capital Group first reported a position in Inogen in Q1 2020 and held it in 8 quarters.
  • Chatham Capital Group's Inogen position peaked at $1.47M in Q2 2021.
  • 149 funds tracked by Wall St. Rank held Inogen as of Q1 2022.

Based on Chatham Capital Group's 13F filing for Q1 2022, filed 21 Apr 2022.